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ABSTRACT
Introduction: Gestational diabetes mellitus (GDM) is associated to increased rates of 
large for gestational age (LGA) newborns and macrosomia. Several charts are used 
to classify birth weight. Is there an ideal chart to classify newborns of GDM mothers?
Methods: We evaluated adequacy of birth weight of 332 neonates born to GDM 
mothers at Hospital de Clínicas de Porto Alegre, Brazil. Newborns were classified 
according to gestational age as small (SGA), adequate, or large (LGA) based on 
four charts: Alexander, Pedreira, INTERGROWTH 21st Project, and SINASC-2012. 
The latter was built using data from a large national registry of 2012, the Born Alive 
National Surveillance System (Sistema de Informações de Nascidos Vivos – SINASC), 
which included 2,905.789 birth certificates. Frequencies of SGA and LGA and Kappa 
agreement were calculated.
Results: In non-gender adjusted curves, SGA rates (95% confidence interval) varied 
from 8% (5-11) to 9% (6-13); LGA rates, from 11% (8-15) to 17% (13-21). For males, 
SGA rates varied from 3% (1-6%) to 6% (3-11%), and LGA rates, from 18% (13-24%) 
to 31% (24-38%); for females, SGA rates were from 3% (1-7%) to 10% (6-16%) and 
LGA rates, from 11% (6-16%) to 19% (13-26%). Kappa results were: ALEXANDER vs. 
SINASC-2012: 0.80 (0.73-0.88); INTERGROWTH 21st vs. SINASC-2012 (adjusted 
by sex): 0.62 (0.53-0.71); INTERGROWTH 21st vs. PEDREIRA: 0.71 (0.62-0.79); 
SINASC-2012 (by sex) vs. PEDREIRA: 0.86 (0.79-0.93).
Conclusions: Misclassification has to be taken into account when evaluating newborns 
of GDM mothers, as LGA rates can almost double depending on the chart used to 
classify birth weight.
Keywords: Gestational diabetes; birth weight charts; large for gestational age newborn; 
small for gestational age newborn
Newborn birth weight classification according to gestational age is an 
important issue due to immediate and lifelong health consequences. For babies 
born too small, neonatal hypoglycemia, polycythemia, hyper viscosity1 and 
higher mortality are of immediate concern, whereas lifelong consequences 
include increased risk of ischemic heart disorders, diabetes, hypertension and 
chronic kidney disease2, as supported by the Barker’s syndrome hypothesis3.
Conversely, those born bigger may have birth injury, hypoglycemia, icterus 
and prolonged hospitalization4. Moreover, they carry a higher risk of developing 
obesity in later life and type 2 diabetes5, in infants of diabetic mothers.
More than 100 curves relating birth weight and gestational age are available, 
most of them built upon regional or local registries6. The American Alexander’s 
chart is our reference curve7, although one based on a large nationwide 
registry was suggested in the past8. In an attempt to unify newborn birth 
weight classification worldwide, a new chart was recently proposed6. It was 
constructed based on prospective data collected in eight “geographically 
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defined urban populations” and included thousands 
of babies, with the intention of being endorsed by 
the World Health Organization.
Gestational diabetes mellitus (GDM) is a common 
cause of excessive birth weight, expressed either as 
large for gestational age (LGA) or as macrosomia9 
(usually, defined as birth weight higher than 4,000 g). 
Recent meta-analyses described an increased rate 
of LGA and macrosomia for GDM women9,10, which 
can be decreased by treatment11 without increasing 
small for gestational age (SGA) rates11,12.
In this paper, our first objective was to plot a curve 
based on data from a large national registry of 2012, 
the Born Alive National Surveillance System (Sistema 
de Informações de Nascidos Vivos – SINASC)13, 
creating the SINASC-2012 chart. The second 
objective was to compare newborn classification 
using four different birth weight curves applied to 
GDM pregnancies: Alexander chart7, Pedreira chart8, 
the INTERGROWTH 21st Project (INTERGROWTH 
21st) chart6 and finally, the new SINASC-2012 chart.
METHODS
From a cohort study described elsewhere14, we 
evaluated adequacy of birth weight of neonates born 
to gestational diabetes mothers. All pregnant women 
referred to the Hospital de Clínicas de Porto Alegre, a 
Brazilian university hospital that delivers tertiary care, 
from November 2009 to May 2013, were enrolled 
in the study. Gestational diabetes was diagnosed 
according to the Brazilian diagnostic criteria until 
201015; after this year, GDM was diagnosed according 
to the IADPSG criteria16. Women were followed during 
the antenatal period by a multidisciplinary team, and 
delivered at the hospital. Birth weight was measured 
according to routine procedures – at the delivery room, 
after initial newborn care, without clothes - using a 
digital scale with weight range from 125 g to 15 kg 
and precision of 5 g (Filizola Baby).
In order to construct the SINASC-2012 curve, 
2,905,789 birth certificates of Brazilian babies born 
in 2012 in the whole country were analyzed13. Valid 
cases were all single alive newborns delivered 
between 32-45 weeks of gestation, without gross 
malformations and whose mothers were between 
15 and 40 years old. We excluded cases with 
missing information on fetal sex and babies weighing 
less than 702 g or more than 5,700 g, resulting in 
2,452,774 newborns for analysis. The distributions 
of birth weight were built by gestational age and the 
10th, 50th, and 90th percentiles were plotted at first 
irrespective of sex, and then stratified by gender. 
Newborns were classified as SGA if birth weight was 
<10th percentile for gestational age and as LGA if 
birth weight >90th percentile.
We compared the cut points for the 10th, 50th 
and 90th percentiles of these newborns’ weight 
with those of the reference curves. Except for the 
Alexander chart, birth weight was originally stratified 
by gestational age and sex in all others.
The four charts we compared were:
1) Alexander et al.7, an American chart that is 
reference in our hospital, classifies babies 
according to gestational age and is adjusted for 
sex only for the 10th percentile;
2) Pedreira et al.8, which was built based on 7,993,166 
certificates of birth weight from Brazilian babies 
delivered from 2003 to 2005, with data plotted for 
3-week intervals of gestational age, stratified by 
sex, with interpolation of calculated birth weights 
for the gestational ages in the intervals;
3) INTERGROWTH-21st6, intended to be the adopted 
by the World Health Organization;
4) SINASC-2012 chart.
Kappa statistic was used to evaluate agreement 
between different reference curves when applied to 
the GDM cohort. Agreement strength was classified 
as: <0.00, poor; 0.00-0.20, slight; 0.21-0.40, fair; 
0.41-0.60, moderate; 0.61-0.80, substantial; 0.81-1.00, 
almost perfect17. Analyses were performed with the 
SPSS 18 package; 95% confidence intervals (95%CI) 
were calculated with the WinPepi package18.
RESULTS
Data was available for 332 newborns of GDM 
women. Maternal age ranged from 16 to 46 years 
(mean 31 ± 6 years), 205 women (62%) had 
a partner, 244 (74%) referred white skin color, 
238 (72%) completed secondary school, 177 (53%) 
had a first-degree history of diabetes, 298 (90%) 
were non-smokers; 155 (47%) were treated only 
with diet, 141 (43%) had vaginal delivery, 13 (4%) 
presented shoulder dystocia and 46 (14%) of the 
women remained with some glucose abnormality 
after delivery. Macrosomia (birth weight ≥ 4,000 g) 
occurred in 24 newborns (7.2%) and low birth weight 
(<2,500 g) in 27 (8.1%). Perinatal death occurred in 
4 cases (1.2%), 50 (15.1%) had jaundice requiring 
phototherapy, 39 (9%) had hypoglycemia requiring 
intensive care management, 53 (16%) needed 
prolonged hospitalization after delivery (more than 
5 days) and 14 (4%) presented some malformation.
1) Results for objective 1 – Building the SINASC-2012 
curve
Clinical characteristics of the 2,452.774 Brazilian 
pregnant women whose newborns’ birth weight were 
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used to construct the SINASC-2012 chart were: mean 
age, 26 ± 6 years (range 15-39 years); 57% had a 
partner, 79% had completed secondary school, 39% 
were white, 6% were black, 54.5% were an admixture 
of black and white, less than 1% were indigenous 
people or from oriental origin. Mean newborn weight 
was 3,226 ± 486 g (range 705-5,730 g), with mean 
1-minute Apgar score of 8 ± 1 and 5-minute Apgar 
score of 9 ± 1. Mean gestational age at delivery was 
39 ± 2 weeks. Table 1 displays the 10th, 50th and 
90th percentiles for each gestational age based on 
SINASC data13, both for the complete sample and 
according to sex.
2) Objective 2 – Evaluating SGA and LGA frequencies 
in GDM pregnancies
In Table 2 we present frequencies of SGA and LGA 
in the GDM cohort according to each chart. In some 
curves, birth weight was not set according to sex; 
therefore we further stratified analyses by newborn 
gender. The use of Alexander’s and SINASC-2012 
Table 1: SINASC-2012 chart: birth weight (g) according to gestational age for percentiles 10, 50 and 90 (total sample 
and stratified by sex).
Gestational 
week N
10th percentile
(g)
50th percentile
(g)
90th percentile
(g)
Total Male Female Total Male Female Total Male Female
32 13 728 1 395 1 445 1 355 2135 2 150 2 110 3 155 3 165 3 150
33 21 842 1 650 1 690 1 605 2440 2 445 2 435 3 300 3 315 3 290
34 37 546 1 895 1 934 1 855 2655 2 686 2 625 3 430 3 460 3 400
35 62 526 2 125 2 170 2 090 2824 2 865 2 780 3 580 3 625 3 510
36 110225 2 315 2 350 2 280 2920 2 970 2 870 3 595 3 635 3 530
37 242289 2 520 2 575 2 475 3060 3 115 3 000 3 650 3 700 3 580
38 549044 2 690 2 745 2 645 3190 3 250 3 125 3 740 3 800 3 660
39 680347 2 780 2 835 2 735 3280 3 340 3 215 3 828 3 890 3 750
40 459549 2 840 2 900 2 795 3360 3 420 3 300 3 930 4 000 3 850
41 181429 2 850 2 910 2 800 3395 3 460 3 330 3 985 4 050 3 900
42 61 065 2 800 2 850 2 750 3350 3 410 3 287 3 950 4 010 3 870
43 22 145 2 790 2 845 2 730 3335 3 400 3 275 3 910 3 980 3 845
44 11 039 2 785 2 850 2 735 3340 3 400 3 270 3 920 4 000 3 844
Table 2: Adequacy of birth weight of 332 neonates born to GDM mothers according to four different charts.
Birth weight chart
N* SGA % (95% CI) LGA
% (95% CI)Original curves not divided by sex
Total sample
Alexander et al. (1996)7 332 31 9 (6-13) 37 11 (8-15)
SINASC-2012* 332 25 8 (5-11) 55 17 (13-21)
Male
Alexander et al. (1996)7 178 11 6 (3-11) 27 15 (10-21)
SINASC-2012 178 7 4 (2-8) 40 22 (17-29)
Female
Alexander et al. (1996)7 154 20 13 (8-19) 10 6 (3-12)
SINASC-2012 153 18 12 (7-18) 15 10 (6-16)
Original curves divided by sex
Male
Pedreira et al. (2011)8 178 6 3 (1-7) 32 18 (13-24)
SINASC-2012 178 11 6 (3-11) 33 19 (14-26)
INTERGROWTH 21st (2014)6 177 5 3 (1-6) 54 31 (24-38)
Female
Pedreira et al. (2011)8 154 6 4 (1-8) 17 11 (7-17)
SINASC-2012 153 15 10 (6-16) 16 11 (6-16)
INTERGROWTH 21st (2014)6 151 4 3 (1-7) 29 19 (13-26)
SGA: small for gestational age; LGA: large for gestational age; 95%; CI: 95% confidence interval. *SINASC-2012 (Table 1, present paper).
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curves resulted in similar rates of SGA, while LGA 
rates were more heterogeneous in the two curves 
not stratified by sex. The curves originally divided 
by sex showed similar rates of SGA for male and 
female newborns, except for females evaluated with 
the SINASC-2012 chart. In general, frequencies of 
LGA were 50% lower when applying the Alexander 
curve and not stratified by sex. In those originally 
divided by sex, LGA rates were consistently higher, 
almost twofold, in the INTERGROWTH-21st chart, 
for both newborn genders.
For male newborns, there were no differences of 
SGA frequencies, neither between the two Brazilian 
charts (SINASC-2012 6% vs. Pedreira 3%, p=0.320) 
nor for the comparison of the SINASC-2012 vs. 
INTERGROWTH 21st (6% vs. 3%, p=0.200). Rates 
of LGA were different comparing the SINASC-2012 
and the INTERGROWTH 21st charts (19% vs. 31%, 
p=0.010), but not when we compared SINASC-2012 
and Pedreira (18% vs. 19%, p>0.999).
For female newborns, rates of SGA were different 
between the Brazilian charts (SINASC-2012 10% vs. 
Pedreira 4%, p=0.044) as well as when comparing 
the SINASC-2012 with the INTERGROWTH 21st 
chart (SINASC-2012 10% vs. INTERGROWTH 21st 
3%, p=0.016). LGA rates were similar between the 
Brazilian charts (SINASC-2012 11% vs. Pedreira 11%, 
p> 0.999) and different in the comparison between 
SINASC-2012 11% vs. INTERGROWTH 21st 19%, 
p=0.036. Birth weight percentiles of newborns delivered 
in GDM pregnancies, compared against the charts 
of Alexander, SINASC-2012 and INTERGROWTH 
21st, are presented in Figure 1.
Kappa agreement results were substantially 
high or almost perfect in most of the comparisons 
(table 3). The lowest concordance was between the 
Figure 1: Birth weight percentiles in newborns of GDM women compared to standard birth weight curves. *Alexander 
(1996): newborn birthweight for percentiles 50th and 90th not divided by sex. Data from: Alexander7, Intergrowth 21st 
Project6 and SINASC-2012 (Table 1).
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INTERGROWTH-21st and both of the Brazilian curves. 
The best Kappa value was found for male newborns 
when we compared the two Brazilian curves.
CONCLUSIONS
In this cohort of 332 newborns from GDM pregnancies, 
frequencies of SGA and LGA varied considerably 
according to the chart used. SGA rates were very low 
for both male (2.8%) and female newborns (2.6%) 
when using the international INTERGROWTH-21st 
chart. LGA frequencies can almost double, depending 
on the chosen chart, from ~18% to ~30% in male and 
from ~11% to ~19% in female newborns.
Rates of male SGA newborns were similar for the two 
charts based on national registries, even considering 
that the first one was built upon data collected more 
than 10 years ago, and grouped gestational age 
at three-week intervals8. In female newborns, an 
unexpectedly higher rate of SGA was found when 
applying the contemporary curve, SINASC-2012, 
compared to the late Pedreira, a finding we could not 
thoroughly clarify herein because we did not adjust 
frequencies to potential confounders like smoking or 
hypertension in pregnancy. One explanation could be 
that the frequency of these confounders might have 
increased along time, negatively affecting birth weight.
LGA rates were similar between the two Brazilian 
curves, but significantly higher when we applied the 
international INTERGROWTH-21st curve6 both for 
male and female babies, raising the question that 
maybe an international chart might prove itself difficult 
to be adopted due to this kind of difference.
Why is birth weight classification in GDM a 
matter of concern? First, it was recently suggested 
that, in order to compare different studies on the 
subject, standardized outcome definitions would 
be necessary19. In a systematic review, 19 different 
definitions were used to classify large for gestational 
age, thus leading to 19 possible different results and 
study conclusions19. Different charts could further 
complicate the interpretation of those rates, as 
birth weight classification cut points for the same 
gestational age can be very different among them. 
Besides outcome definitions, another problem was 
recently raised by a German group: plotting errors 
could cause a “leftward shift” on the curves, raising 
SGA and diminishing LGA rates, thus potentially 
misclassifying around 5% of the babies20. Second, 
meta-analyses described an increased risk of macrosomia 
and LGA in women with gestational diabetes9,10, 
irrespective of the diagnostic criteria. Three other 
meta-analyses showed consistent benefits of GDM 
treatment, with protective effects concerning LGA 
and macrosomia, without increasing SGA rates11,12,21. 
As an obvious consequence of the most employed 
definitions, SGA and LGA frequencies are expected 
to be 10% each. In non-treated GDM pregnancies, 
Wendland et al. reported a LGA incidence of 14.5% 
in 3 054 women when 1999-WHO criteria were used, 
with a relative risk (RR) of 1.81 (95% CI 1.47-2.22) 
and of 15.4% in 6201 women with the IADPSG criteria 
(RR 1.38 95% CI 1.14-1.68)9, compared to non-GDM 
women. Treatment of GDM significantly reduces LGA 
rates without increasing the risk of SGA babies12. 
The frequency of LGA was 14.8% of 2 245 women 
in a meta-analysis including four treatment studies; 
based on three studies, the frequency of SGA was 
7%11. In a large American cohort of treated GDM 
women (n = 7,468), the frequency of LGA adjusted 
for maternal age varied from 13.9% in Asian women, 
to 25.1% in African-American women, and reached 
frequencies higher than 20% in obese women when 
further adjusted to BMI, in all racial groups22. Third, 
classification of babies carries some prognostic 
implications, both in short- and long-term; therefore, 
misclassification could lead to potential mistreatment 
or overtreatment1,20. For example, a low birth weight 
(< 2,500 g) could imply an increased risk of mortality 
and of neurological morbidities23.
In an attempt to standardize newborn charts, the 
INTERGROWTH-21st project prospectively evaluated 
more than 20,000 women for four years and sex-specific 
curves for weight, length and head circumference 
according to gestational age at delivery were plotted. 
The authors concluded that the development of 
Table 3: Kappa coefficient (95% confidence interval) of selected newborn adequacy charts in GDM pregnancy.
Comparison Total sample p Male p Female p
ALEXANDER 1996
vs. SINASC-2012
0.80 (0.73-0.88) 0.000 0.75 (0.64-0.86) 0.000 0.87 (0.77-0.96) 0.03
INTERGROWTH 21st  
vs. SINASC-2012 (by sex)
0.62 (0.53-0.71) 0.000 0.65 (0.54-0,77) 0.000 0.57 (0.41-0.72) <0.001
INTERGROWTH 21st 
vs. PEDREIRA
0.71 (0.62-0.79) 0.000 0.69 (0.58-0.80) 0.000 0.72 (0.58-0.86) 0.002
SINASC-2012 (by sex) 
vs. PEDREIRA
0.86 (0.79-0.93) 0.001 0.91 (0.84-0.98) 0.007 0.79 (0.66-0.91) 0.05
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“international anthropometric standards to assess 
newborn size that are intended to complement the WHO 
Child Growth Standards” would “allow comparisons 
across multiethnic populations”6. Unexpectedly, in our 
cohort, the use of the INTERGROWTH 21st charts 
almost doubled rates of LGA newborns, both male 
and female, indicating that, at least for babies born 
to GDM women, an increased rate of large newborns 
can be expected when adopting the international 
standard. Conversely, significantly lower rates of 
SGA would be found for female SGA newborns with 
this new chart.
Alternatives to overcome these problems must 
be sought. Several authors suggest the adoption of 
specific curves for each population group24-26. Other 
possibility would be to consider only extremes of 
weight as cut points, such as macrosomia (either 
>4,000 g or >4,500 g) or low birth weight (<2,500 g or 
even <1,500 g). At least for low birth weight, absolute 
weight was more accurate than percentiles to predict 
neonatal adverse outcomes23. In our cohort, around 
7% of babies would be labeled as macrosomic 
(>4,000 g), compared to 14.5% observed in a 
meta-analysis of six experimental studies on GDM 
treatment11. This outcome was considered as being 
of “critical importance” by the authors11.
Scarce information exists on low birth weight 
occurrence in GDM, as this is not an expected 
outcome. Maternal hyperglycemia, the hallmark of 
GDM, leads to fetal hyperinsulinism and overgrowth, 
therefore being associated to the delivery of LGA 
babies27. Nevertheless, SGA frequency was around 
7% in the above meta-analysis11, similar to our own 
rate (8.1%).
One of the strengths of our study was the number of 
newborns of GDM women employed for the evaluation 
of several birth weight charts. A second point was 
the possibility of building a national curve, which, to 
our knowledge, is the first one with sequential birth 
weight values for each gestational week after week 
32. It included a large number of babies and, as it 
was generated from a large national database, it 
is representative of the birth weight pattern across 
the country.
Limitations of the study would be the scarce 
numbers of birth weight values in extremes of 
gestational age and the inclusion of GDM women 
with two different diagnostic criteria. Regarding the 
latter point, analysis of maternal clinical baseline 
characteristics and of the main fetal and neonatal 
outcomes did not disclose differences between both 
criteria. An important limitation of the SINASC-2012 
chart relates to inconsistencies of birth weight values 
in early gestational ages, probably due to errors 
or incompleteness of data transcription. A bimodal 
pattern of birth weight distribution at lower gestational 
ages was found in our preliminary analyses, thus 
precluding the assignment of birth weight values for 
gestational ages lower than 32 weeks. Potential errors 
in the SINASC registries were previously described28. 
Coverage was in general adequate, more than 90%; 
greater inconsistency was found for “the mother’s 
educational level, number of prior childbirths and 
frequency of prenatal visits”28; information regarding 
parity was the most incomplete, but there was no 
description of an eventual bimodal distribution of birth 
weight in earlier pregnancy ages28. Another potential 
limitation of our curve would be plotting errors, as 
described above20.
In conclusion, the adoption of different charts to 
classify newborn birth weight can lead to different 
rates of SGA and LGA babies in GDM pregnancies. 
The adoption of an international standard implies a 
higher, almost twice, LGA frequency and, in female 
babies, lower SGA frequencies. Strategies to improve 
birth weight classification to avoid misclassification 
of babies born to GDM mothers must be sought. 
Perhaps an internationally accepted birth weight chart, 
and, furthermore, the adoption of an international 
diagnostic criterion for GDM, would improve power 
and quality of studies on GDM management, as well 
as birth weight classification, worldwide.
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